The largest database of trusted experimental protocols

Dharmafect formulation 4

Manufactured by Thermo Fisher Scientific

DharmaFECT formulation 4 is a transfection reagent for the delivery of nucleic acids into mammalian cells. It is designed to effectively transfect a wide range of cell types with high efficiency.

Automatically generated - may contain errors

3 protocols using dharmafect formulation 4

1

Optimized Silencing of CTNNB1 and WLS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Smartpool ON-TARGETplus siRNAs targeting CTNNB1 and WLS were obtained from Dharmacon. The ON-TARGETplus nontargeting siRNA #2 was used as negative control. Cells were reverse-transfected in a 96-well plate using a total of 0.2 μl DharmaFECT formulation 4 (Thermo Fischer Scientific) and 25 nM of each siRNA per well. Following 72 hours of incubation, the effect on knockdown was determined by Western blotting.
+ Open protocol
+ Expand
2

Targeted siRNA Knockdown Across Wnt Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
SiRNA-mediated gene knockdown was performed as reported previously14 (link),50 (link). Smartpool ON-TARGETplus siRNAs targeting AXIN1, AXIN2 or APC were purchased from Dharmacon (Supplemental Table S4). The ON-TARGETplus Non-targeting siRNA #2 was used as negative control. Cells were reverse-transfected in a 24-well plate using a total of 0.8 µl DharmaFECT formulation 4 (Thermo-Fisher Scientific) and 25 nM of each siRNA per well. Following 72 h incubation, the effect of knock-down was tested by qRT-PCR. Alternatively, for combined siRNA/β-catenin reporter assays, the siRNAs were co-transfected with WRE or MRE vectors and CMV-Renilla using lipofectamin 2000, and measured after 48 h.
+ Open protocol
+ Expand
3

siRNA-mediated Knockdown and β-catenin Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Smartpool ON-TARGETplus siRNAs targeting STRAP were purchased from Dharmacon. The ON-TARGETplus Non-targeting siRNA #2 was used as negative control. Cells were reversetransfected in a 24-well plate using a total of 0.8 µl DharmaFECT formulation 4 (Thermo Fischer Scientific) and 25nM of each siRNA per well. Following 72 h incubation, the effect of knockdown was tested by western blotting. Alternatively, 48h after reverse transfection, the cells were transfected with WRE or MRE vectors and CMV-Renilla for β-catenin reporter assay.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!